Product correctly added to cart.

N-Hydroxy-7-(4-dimethylaminobenzoyl)aminoheptanamide
View 3D

Biosynth logo

N-Hydroxy-7-(4-dimethylaminobenzoyl)aminoheptanamide

CAS: 251456-60-7

Ref. 3D-FH24290

5mgDiscontinued
10mgDiscontinued
25mgDiscontinued
50mgDiscontinued
100mgDiscontinued

Discontinued product. For inquiries about similar products, please fill out our form or email us at .


Product Information

Name:
N-Hydroxy-7-(4-dimethylaminobenzoyl)aminoheptanamide
Synonyms:
  • 4-(Dimethylamino)-N-[7-(hydroxyamino)-7-oxoheptyl]benzamide
  • Benzamide, 4-(dimethylamino)-N-[7-(hydroxyamino)-7-oxoheptyl]-
Description:

N-Hydroxy-7-(4-dimethylaminobenzoyl)aminoheptanamide is a hydroxamic acid that inhibits the activity of cyclin D2, which is required for cells to progress through the G1 phase of the cell cycle. This drug may also inhibit histone deacetylase and have an effect on epigenetic modulators. N-Hydroxy-7-(4-dimethylaminobenzoyl)aminoheptanamide has been shown to induce apoptosis in cancer cells, and can be used as a combination therapy with suberoylanilide hydroxamic acid or suberoylanilide. This drug may also act as a toll-like receptor 4 (TLR4) inhibitor.

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
307.39 g/mol
Formula:
C16H25N3O3
Purity:
Min. 95%
InChI:
InChI=1S/C16H25N3O3/c1-19(2)14-10-8-13(9-11-14)16(21)17-12-6-4-3-5-7-15(20)18-22/h8-11,22H,3-7,12H2,1-2H3,(H,17,21)(H,18,20)
InChI key:
InChIKey=MXWDSZWTBOCWBK-UHFFFAOYSA-N
SMILES:
CN(C)c1ccc(C(=O)NCCCCCCC(=O)NO)cc1
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Inquiry about discontinued product: 3D-FH24290 N-Hydroxy-7-(4-dimethylaminobenzoyl)aminoheptanamide

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".